Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH
Withdrawn before enrolling · Not applicable
Conditions studied: Breast Cancer
In brief
The purpose of this study is to determine if an avatar-based depression self-management intervention (eSMART-MH) once a week for the duration of the participant's radiation treatment will significantly reduce depressive symptoms. Investigators also seek to explore how women with breast cancer describe their mood using prompted and unprompted speech through electronic social media and interviews. Participants will be randomized into the eSMART-MH group or the theater testing (attention control) group. In addition to the assigned interventions, participants will be asked to complete questionnaires and interviews with the study staff.
Key facts
- Study ID
- NCT02759549
- Run by
- Emory University
- People needed
- 0
- Starts
- 2015-09-01
- Last updated by the study team
- 2016-11-15
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients seen in the Emory Breast Center at The Emory Clinic and Emory Midtown Hospital who are treated with curative intent.
- Score of 8 or higher on the Inventory of Depressive Symptomology - Self Reported (IDS-SR) test
Where it is running
- Emory Clinic — Atlanta, Georgia, United States
- Emory University Hospital Midtown — Atlanta, Georgia, United States
- Emory University Hospital — Atlanta, Georgia, United States
- Winship Cancer Institute — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.